|
1）Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997; 99 Suppl 2: S1-5
|
|
|
|
2）Kuriyama S, Kusaka Y, Fujimura M, et al. Pre-valence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008; 39: 42-7
|
|
|
|
|
3）Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008; 79: 900-4
|
|
|
|
|
|
4）Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006; 77: 1025-9
|
|
|
|
|
|
5）Fukui M, Kono S, Sueishi K, et al. Moyamoya disease. Neuropathology. 2000; 20 Suppl: S61-4
|
|
|
|
|
|
6）Nanba R, Kuroda S, Tada M, et al. Clinical features of familial moyamoya disease. Childs Nerv Syst. 2006; 22: 258-62
|
|
|
|
|
|
7）Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo). 1992; 32: 883-6
|
|
|
|
|
8）Suzuki J, Kodama N. Moyamoya disease--a review. Stroke. 1983; 14: 104-9
|
|
|
|
|
|
9）Yonekawa Y, Ogata N, Kaku Y, et al. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg. 1997; 99 Suppl 2: S58-60
|
|
|
|
|
|
10）Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008; 7: 1056-66
|
|
|
|
|
|
11）Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999; 64: 533-7
|
|
|
|
|
|
12）Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004; 49: 278-81
|
|
|
|
|
|
13）Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008; 70: 2357-63
|
|
|
|
|
|
14）Inoue TK, Ikezaki K, Sasazuki T, et al. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000; 15: 179-82
|
|
|
|
|
|
15）Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moya-moya disease, along with thoracic aortic disease. Am J Hum Genet. 2009; 84: 617-27
|
|
|
|
|
|
16）Shimojima K, Yamamoto T. ACTA2 is not a major disease-causing gene for moyamoya disease. J Hum Genet. 2009; 54: 687-8
|
|
|
|
|
|
17）Miskinyte S, Butler MG, Herve D, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011; 88: 718-28
|
|
|
|
|
|
18）Xin B, Jones S, Puffenberger EG, et al. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc Natl Acad Sci U S A. 2011; 108: 5372-7
|
|
|
|
|
|
19）Roder C, Peters V, Kasuya H, et al. Polymorphisms in TGFB1 and PDGFRB are associated with Moyamoya disease in European patients. Acta Neurochir (Wien). 2010; 152: 2153-60
|
|
|
|
|
|
20）Kang HS, Kim SK, Cho BK, et al. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006; 58: 1074-80; discussion -80
|
|
|
|
|
|
21）Liu W, Hashikata H, Inoue K, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010; 15: 94-104
|
|
|
|
|
|
22）Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000; 31: 930-5
|
|
|
|
|
|
23）Nanba R, Tada M, Kuroda S, et al. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst. 2005; 21: 62-8
|
|
|
|
|
|
24）Kamada F, Aoki Y, Narisawa A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011; 56: 34-40
|
|
|
|
|
|
25）Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moya-moya disease and its possible role in vascular Development. PloS One. 2011; 6: e22542
|
|
|
|
|
|
26）Miyatake S, Miyake N, Touho H, et al. Homozygous c. 14576G＞A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012; 78: 803-10
|
|
|
|
|
|
27）Lupas AN, Martin J. AAA proteins. Curr Opin Struct Biol. 2002; 12: 746-53
|
|
|
|
|
|
28）Miyawaki S, Imai H, Takayanagi S, et al. Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion. Stroke. 2012; 43: 3371-4
|
|
|
|
|
|
29）Koizumi A, Kobayashi H, Liu W, et al. P. R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013; 18: 121-9
|
|
|
|
|
|
30）Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010; 11: 446-50
|
|
|
|
|
|
31）Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461: 747-53
|
|
|
|
|
|
32）Miyatake S, Touho H, Miyake N, et al. Sibling cases of moyamoya disease having homozygous and heterozygous c. 14576G＞A variant in RNF213 showed varying clinical course and severity. J Hum Genet. 2012; 57: 804-6
|
|
|
|
|
|
33）Kim SK, Cho BK, Phi JH, et al. Pediatric moya-moya disease: An analysis of 410 consecutive cases. Ann Neurol. 2010; 68: 92-101
|
|
|
|
|
|
34）Yamada I, Himeno Y, Suzuki S, et al. Posterior circulation in moyamoya disease: angiographic study. Radiology. 1995; 197: 239-46
|
|
|
|
|
|
35）Kim SK, Seol HJ, Cho BK, et al. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004; 54: 840-4
|
|
|
|
|
|
36）Mugikura S, Higano S, Shirane R, et al. Posterior circulation and high prevalence of ischemic stroke among young pediatric patients with Moya-moya disease: evidence of angiography-based differences by age at diagnosis. AJNR Am J Neuroradiol. 2011; 32: 192-8
|
|
|
|
|
|
37）Southerland AM, Meschia JF, Worrall BB. Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia. Curr Opin Neurol. 2013; 26: 13-28
|
|
|
|
|